About Fulcrum Pharma In a global market where regulations are changing rapidly it is essential to obtain advice that is practical, current and independent. Fulcrum offers easy access to pragmatic advice, based on solid experience and an in-depth knowledge of the regulatory landscape. What We Offer Fulcrum provides the full range of drug development and regulatory expertise essential to progress a development programme from research to product approval. We work with many clients from lead candidate selection through to non-clinical and pharmaceutical development and all phases of clinical development. We provide support for product registration, launch and in-market maintenance. Our drug development experts provide technical input to the design and implementation of client development programmes. Our regulatory and safety experts provide the strategic and operational support to ensure successful approval at every stage of the development and post-marketing process. Consulting Development Regulatory Safety
Looking for a particular Fulcrum Pharma Developments employee's phone or email?
The Fulcrum Pharma Developments annual revenue was $26 million in 2026.
Bushra Agha is the Vice President, Pharmaceutical Development of Fulcrum Pharma Developments.
5 people are employed at Fulcrum Pharma Developments.
Fulcrum Pharma Developments is based in Morrisville, North Carolina.
The NAICS codes for Fulcrum Pharma Developments are [32, 325, 32541, 3254].
The SIC codes for Fulcrum Pharma Developments are [28, 283, 2834].